Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4.
Saved in:
| Title: | Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4. |
|---|---|
| Authors: | Liu CH; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada., Leu SJ; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan., Lee CH; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Lin CY; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Wang WC; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Tsai BY; Navi Bio-Therapeutics Inc., Taipei, Taiwan., Lee YC; The Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan., Chen CL; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University and Taipei Medical University Hospital, Taipei, Taiwan., Yang YY; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Core Laboratory of Antibody Generation and Research, Taipei Medical University, Taipei, Taiwan., Lin LT; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Jan 15; Vol. 14, pp. 1292019. Date of Electronic Publication: 2024 Jan 15 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38288120 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+CH%22">Liu CH</searchLink>; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.<br /><searchLink fieldCode="AU" term="%22Leu+SJ%22">Leu SJ</searchLink>; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+CH%22">Lee CH</searchLink>; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CY%22">Lin CY</searchLink>; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+WC%22">Wang WC</searchLink>; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tsai+BY%22">Tsai BY</searchLink>; Navi Bio-Therapeutics Inc., Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+YC%22">Lee YC</searchLink>; The Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+CL%22">Chen CL</searchLink>; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University and Taipei Medical University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+YY%22">Yang YY</searchLink>; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Core Laboratory of Antibody Generation and Research, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+LT%22">Lin LT</searchLink>; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Jan 15; Vol. 14, pp. 1292019. <i>Date of Electronic Publication: </i>2024 Jan 15 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38288120 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1292019 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1292019 Titles: – TitleFull: Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu CH – PersonEntity: Name: NameFull: Leu SJ – PersonEntity: Name: NameFull: Lee CH – PersonEntity: Name: NameFull: Lin CY – PersonEntity: Name: NameFull: Wang WC – PersonEntity: Name: NameFull: Tsai BY – PersonEntity: Name: NameFull: Lee YC – PersonEntity: Name: NameFull: Chen CL – PersonEntity: Name: NameFull: Yang YY – PersonEntity: Name: NameFull: Lin LT IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 01 Text: 2024 Jan 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
